Qsemble Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-21,566
Closed -$3.29M 529
2025
Q2
$3.29M Buy
21,566
+16,993
+372% +$2.61M 0.32% 105
2025
Q1
$758K Sell
4,573
-13,643
-75% -$2.13M 0.08% 251
2024
Q4
$2.63M Sell
18,216
-16,461
-47% -$2.55M 0.35% 106
2024
Q3
$5.62M Buy
34,677
+13,440
+63% +$2.14M 1.03% 5
2024
Q2
$3.1M Buy
21,237
+2,016
+10% +$300K 0.59% 43
2024
Q1
$3.04M Buy
19,221
+14,096
+275% +$2.24M 0.66% 21
2023
Q4
$803K Sell
5,125
-11,475
-69% -$1.76M 0.2% 181
2023
Q3
$2.59M Buy
+16,600
New +$2.74M 0.48% 74
2023
Q2
Sell
-10,800
Closed -$1.67M 277
2023
Q1
$1.67M Buy
10,800
+1,600
+17% +$258K 1.13% 8
2022
Q4
$1.63M Buy
+9,200
New +$1.59M 1.13% 20

Other funds holding JNJ

Qsemble Capital Management's JNJ Position: Q3 2025 in Review

Qsemble Capital Management sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 21,566 shares — an estimated $3.29M sold.

Qsemble Capital Management first reported a position in JNJ in Q4 2022 and held it in 10 quarters. The position peaked at $5.62M in Q3 2024. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Qsemble Capital Management reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Qsemble Capital Management sold 21,566 Johnson & Johnson shares in Q3 2025, an estimated $3.29M.
  • Qsemble Capital Management first reported a position in Johnson & Johnson in Q4 2022 and held it in 10 quarters.
  • Qsemble Capital Management's Johnson & Johnson position peaked at $5.62M in Q3 2024.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Qsemble Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.